Overcoming Therapeutic Resistance of Bone Sarcomas

Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells

Tomohiro Fujiwara, Toshihumi Ozaki

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Bone sarcomas are heterogeneous malignant tumors that exhibit clinical, histological, and molecular heterogeneity. Recent progress in their multimodal treatment has gradually improved patient prognosis; however, drug resistance and distant metastasis remain unresolved clinical problems. Recent investigations have suggested the existence of cancer stem-like cells (CSCs) in bone sarcomas, which represent a subpopulation of tumor cells with high tumor-forming ability. The hallmarks of CSCs include tumor-and metastasis-forming potential and drug resistance, which are responsible for poor prognoses of bone sarcoma patients. Therefore, elucidation of the molecular mechanisms of CSCs and identification of therapeutic targets could contribute to novel treatment strategies for bone sarcomas and improve patient prognosis. This paper provides an overview of the accumulating knowledge on bone sarcoma stem cells and preclinical analyses to overcome their lethal phenotypes, in addition to a discussion of their potential for novel therapeutics for bone sarcomas.

Original languageEnglish
Article number2603092
JournalStem Cells International
Volume2016
DOIs
Publication statusPublished - 2016

Fingerprint

Sarcoma
Stem Cells
Bone and Bones
Neoplastic Stem Cells
Drug Resistance
Neoplasms
Therapeutics
Neoplasm Metastasis
Combined Modality Therapy
Phenotype

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

@article{b8d4694ce0624a669aff5e0796e537cf,
title = "Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells",
abstract = "Bone sarcomas are heterogeneous malignant tumors that exhibit clinical, histological, and molecular heterogeneity. Recent progress in their multimodal treatment has gradually improved patient prognosis; however, drug resistance and distant metastasis remain unresolved clinical problems. Recent investigations have suggested the existence of cancer stem-like cells (CSCs) in bone sarcomas, which represent a subpopulation of tumor cells with high tumor-forming ability. The hallmarks of CSCs include tumor-and metastasis-forming potential and drug resistance, which are responsible for poor prognoses of bone sarcoma patients. Therefore, elucidation of the molecular mechanisms of CSCs and identification of therapeutic targets could contribute to novel treatment strategies for bone sarcomas and improve patient prognosis. This paper provides an overview of the accumulating knowledge on bone sarcoma stem cells and preclinical analyses to overcome their lethal phenotypes, in addition to a discussion of their potential for novel therapeutics for bone sarcomas.",
author = "Tomohiro Fujiwara and Toshihumi Ozaki",
year = "2016",
doi = "10.1155/2016/2603092",
language = "English",
volume = "2016",
journal = "Stem Cells International",
issn = "1687-9678",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Overcoming Therapeutic Resistance of Bone Sarcomas

T2 - Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells

AU - Fujiwara, Tomohiro

AU - Ozaki, Toshihumi

PY - 2016

Y1 - 2016

N2 - Bone sarcomas are heterogeneous malignant tumors that exhibit clinical, histological, and molecular heterogeneity. Recent progress in their multimodal treatment has gradually improved patient prognosis; however, drug resistance and distant metastasis remain unresolved clinical problems. Recent investigations have suggested the existence of cancer stem-like cells (CSCs) in bone sarcomas, which represent a subpopulation of tumor cells with high tumor-forming ability. The hallmarks of CSCs include tumor-and metastasis-forming potential and drug resistance, which are responsible for poor prognoses of bone sarcoma patients. Therefore, elucidation of the molecular mechanisms of CSCs and identification of therapeutic targets could contribute to novel treatment strategies for bone sarcomas and improve patient prognosis. This paper provides an overview of the accumulating knowledge on bone sarcoma stem cells and preclinical analyses to overcome their lethal phenotypes, in addition to a discussion of their potential for novel therapeutics for bone sarcomas.

AB - Bone sarcomas are heterogeneous malignant tumors that exhibit clinical, histological, and molecular heterogeneity. Recent progress in their multimodal treatment has gradually improved patient prognosis; however, drug resistance and distant metastasis remain unresolved clinical problems. Recent investigations have suggested the existence of cancer stem-like cells (CSCs) in bone sarcomas, which represent a subpopulation of tumor cells with high tumor-forming ability. The hallmarks of CSCs include tumor-and metastasis-forming potential and drug resistance, which are responsible for poor prognoses of bone sarcoma patients. Therefore, elucidation of the molecular mechanisms of CSCs and identification of therapeutic targets could contribute to novel treatment strategies for bone sarcomas and improve patient prognosis. This paper provides an overview of the accumulating knowledge on bone sarcoma stem cells and preclinical analyses to overcome their lethal phenotypes, in addition to a discussion of their potential for novel therapeutics for bone sarcomas.

UR - http://www.scopus.com/inward/record.url?scp=85009413856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009413856&partnerID=8YFLogxK

U2 - 10.1155/2016/2603092

DO - 10.1155/2016/2603092

M3 - Review article

VL - 2016

JO - Stem Cells International

JF - Stem Cells International

SN - 1687-9678

M1 - 2603092

ER -